Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients

Volume: 20, Issue: 8, Pages: 1072 - 1079
Published: Jan 24, 2018
Abstract
Immunotherapy increases overall response rate (ORR) and overall survival (OS) in patients with non-small-cell lung cancer (NSCLC). Prognostic and predictive factors are a high need. Retrospective review of NSCLC patients treated with nivolumab was performed. Analyzed variables included age, sex, stage, performance status (PS), location of metastases, presence of tumour-related symptoms and comorbidities, number of metastasis locations, previous...
Paper Details
Title
Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients
Published Date
Jan 24, 2018
Volume
20
Issue
8
Pages
1072 - 1079
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.